Electroencephalographic spectrogram–guided total intravenous anesthesia using dexmedetomidine and propofol prevents unnecessary anesthetic dosing during craniotomy: a propensity score–matched analysis

Lin Feng-Sheng,Shih Po-Yuan,Sung Chao-Hsien,Chou Wei-Han,Wu Chun-Yu 대한마취통증의학회 2024 Korean Journal of Anesthesiology Vol.77 No.1

Background: The bispectral index (BIS) may be unreliable to gauge anesthetic depth when dexmedetomidine is administered. By comparison, the electroencephalogram (EEG) spectrogram enables the visualization of the brain response during anesthesia and may prevent unnecessary anesthetic consumption. Methods: This retrospective study included 140 adult patients undergoing elective craniotomy who received total intravenous anesthesia using a combination of propofol and dexmedetomidine infusions. Patients were equally matched to the spectrogram group (maintaining the robust EEG alpha power during surgery) or the index group (maintaining the BIS score between 40 and 60 during surgery) based on the propensity score of age and surgical type. The primary outcome was the propofol dose. Secondary outcome was the postoperative neurological profile.Results: Patients in the spectrogram group received significantly less propofol (1585 ± 581 vs. 2314 ± 810 mg, P < 0.001). Fewer patients in the spectrogram group exhibited delayed emergence (1.4% vs. 11.4%, P = 0.033). The postoperative delirium profile was similar between the groups (profile P = 0.227). Patients in the spectrogram group exhibited better in-hospital Barthel’s index scores changes (admission state: 83.6 ± 27.6 vs. 91.6 ± 17.1; discharge state: 86.4 ± 24.3 vs. 85.1 ± 21.5; group–time interaction P = 0.008). However, the incidence of postoperative neurological complications was similar between the groups.Conclusions: EEG spectrogram–guided anesthesia prevents unnecessary anesthetic consumption during elective craniotomy. This may also prevent delayed emergence and improve postoperative Barthel index scores.

The first record of genus Bruggmanniella (Diptera: Cecidomyiidae) from Taiwan with description of a new species inducing bud galls on Neolitsea parvigemma (Lauraceae)

Sheng-Feng Lin,Makoto Tokuda,Man-Miao Yang 한국응용곤충학회 2019 Journal of Asia-Pacific Entomology Vol.22 No.1

The genus Bruggmanniella Tavares is newly discovered from Taiwan and Bruggmanniella brevipes sp. n. is described as new to science. This is the southernmost species of Bruggmanniella found in the Old World. Furthermore, the gall midge induces bud galls on Neolitsea parvigemma (Hayata) Kaneh (Lauraceae), an endemic species in Taiwan, and the plant genus Neolitsea is the third host genus of Lauraceae-associated Bruggmanniella in East Asia. The knowledge of its distribution and host information provide us to shed the light on evolutionary and biogeography issue of East Asian Bruggmanniella.

Streptomyces Telomeres Contain a Promoter

Lin, Yuh-ru,Hahn, Mi-Young,Roe, Jung-Hye,Huang, Tzu-Wen,Tsai, Hsiu-Hui,Lin, Yung-Feng,Su, Tsung-Sheng,Chan, Yu-Jiun,Chen, Carton W. American Society for Microbiology 2009 Journal of Bacteriology Vol.191 No.3

<B>ABSTRACT</B><P>Bidirectional replication of the linear chromosomes and plasmids of <I>Streptomyces</I> spp. results in single-strand overhangs at their 3′ ends, which contain extensive complex palindromic sequences. The overhangs are believed to be patched by DNA synthesis primed by a terminal protein that remains covalently bound to the 5′ ends of the telomeres. We discovered that in vitro a conserved 167-bp telomere DNA binds strongly to RNA polymerase holoenzyme and exhibits promoter activities stronger than those of an rRNA operon. In vivo, the telomere DNA exhibited promoter activity in both orientations on a circular plasmid in <I>Streptomyces</I>. The telomere promoter is also active on a linear plasmid during exponential growth. Such promoter activity in a telomere has not hitherto been observed in eukaryotic or prokaryotic replicons. <I>Streptomyces</I> telomere promoters may be involved in priming the terminal Okazaki fragment (during replication) replicative transfer (during conjugation), or expression of downstream genes (including a conserved <I>ttrA</I> helicase-like gene involved in conjugal transfer). Interestingly, the <I>Streptomyces</I> telomeres also function as a promoter in <I>Escherichia coli</I> and as a transcription enhancer in yeast.</P>

Performance Analysis of Packet Transport Network Communication for Integrated Wide-Area Protection

Sheng-ming Ge,Z Q Bo,Lin Wang,Zhan-feng Fan,Xing Liu,Feng-quan Zhou 보안공학연구지원센터 2016 International Journal of Grid and Distributed Comp Vol.9 No.3

As a new protection, wide-area protection enables protective relaying, and automatic control based on electric power system network communications and comprehensive judgment of multi-point information, which plays an increasingly important role in the secure and stable operation of electric power system. Interaction of wide-area information relies on communication network featuring high reliability and low time delay. On the other hand, most service of power transformation station is gradually towards IP and data oriented, along with the development of smart grid. This paper aims to introduce the wide-area protection technology supported by Packet Transport Network (PTN) communication technology, with analyzing the QoS (Quality of Service) network assurance architecture of PTN network, which establishes three planes, including transport plane, management plane, and control plane, based on ASON (Automatically Switched Optical Network) technology. After demonstrating the QoS assurance system of PTN from traffic control and transmission route, this paper introduces PTN networking test. Based on detailed parameters in the test results, the transmission performance of PTN on time delay, protection, and time synchronization of various electric power communication services are analyzed, with showing that PTN can fully meet the requirements of electric power communication.

Bone Formation in Ectopic and Osteogenic Tissue Induced by a Novel BMP-2-related Peptide Combined with Rat Tail Collagen

Jing-Feng Li,Zhen-Yu Lin,Qi-Xin Zheng,Xiao-Dong Guo,Shu-Hua Yang,Hong-Wei Lu,Sheng-Hui Lan 한국생물공학회 2010 Biotechnology and Bioprocess Engineering Vol.15 No.5

Bone morphogenetic proteins (BMPs) play an important role in regulating osteoblast differentiation and subsequent bone formation, mainly evidenced by the induced osteogenic ability of BMP-2 from BMPs. However, BMP-2 alone does not induce the expected efficacy due to its short retention in vivo. In this study, a novel BMP-2-related peptide (designated P24) derived from the “knuckle epitope”of BMP-2 was coupled covalently to type I collagen derived from rat tail and observed under scanning electron microscopy (SEM) in low vacuum mode. The BMP-2-related peptide/collagen composite was implanted in vivo into the pocket of the quadriceps musculature of Sprague-Dawley (SD) rats and then harvested 3 or 6 weeks after surgery. It was found that lyophilized collagen retained a porous network structure with an average inner-diameter of 90 ~ 160 μm. Based on radiographic evaluation and histological examination, BMP-2-related peptide/collagen induced significant ectopic bone formation compared to that of rat tail collagen alone as a control. Our results indicate collagen served as a good carrier for newly synthesized BMP-2-related peptide and that the BMP-2-related peptide/collagen composite was an effective substitute in bone tissue engineering.

Mutational Analysis of Key EGFR Pathway Genes in Chinese Breast Cancer Patients

Tong, Lin,Yang, Xue-Xi,Liu, Min-Feng,Yao, Guang-Yu,Dong, Jian-Yu,Ye, Chang-Sheng,Li, Ming Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.11

Background: The epidermal growth factor receptor (EGFR) is a potential therapeutic target for breast cancer treatment; however, its use does not lead to a marked clinical response. Studies of non-small cell lung cancer and colorectal cancer showed that mutations of genes in the PIK3CA/AKT and RAS/RAF/MEK pathways, two major signalling cascades downstream of EGFR, might predict resistance to EGFR-targeted agents. Therefore, we examined the frequencies of mutations in these key EGFR pathway genes in Chinese breast cancer patients. Methods: We used a high-throughput mass-spectrometric based cancer gene mutation profiling platform to detect 22 mutations of the PIK3CA, AKT1, BRAF, EGFR, HRAS, and KRAS genes in 120 Chinese women with breast cancer. Results: Thirteen mutations were detected in 12 (10%) of the samples, all of which were invasive ductal carcinomas (two stage I, six stage II, three stage III, and one stage IV). These included one mutation (0.83%) in the EGFR gene (rs121913445-rs121913432), three (2.50%) in the KRAS gene (rs121913530, rs112445441), and nine (7.50%) in the PIK3CA gene (rs121913273, rs104886003, and rs121913279). No mutations were found in the AKT1, BRAF, and HRAS genes. Six (27.27%) of the 22 genotyping assays called mutations in at least one sample and three (50%) of the six assays queried were found to be mutated more than once. Conclusions: Mutations in the EGFR pathway occurred in a small fraction of Chinese breast cancers. However, therapeutics targeting these potential predictive markers should be investigated in depth, especially in Oriental populations.

Ischemic postconditioning protects cardiomyocytes against ischemia/reperfusion injury by inducing MIP2

Hong-Lin Zhu,Kang-Kai Wang,Xing Wei,Shun-Lin Qu,Chi Zhang,Xiao-Xia Zuo,Yan-Sheng Feng,Qi Luo,Guang-Wen Chen,Mei-Dong Liu,Lei Jiang,Xian-Zhong Xiao 생화학분자생물학회 2011 Experimental and molecular medicine Vol.43 No.8

Cardiomyocytes can resist ischemia/reperfusion (I/R)injury through ischemic postconditioning (IPoC)which is repetitive ischemia induced during the onset of reperfusion. Myocardial ischemic preconditioning up-regulated protein 2 (MIP2) is a member of the WD-40family proteins, we previously showed that MIP2 was up-regulated during ischemic preconditioning (IPC). As IPC and IPoC engaged similar molecular mechanisms in cardioprotection, this study aimed to elucidate whether MIP2 was up-regulated during IPoC and contributed to IPoC-mediated protection against I/R injury. The experiment was conducted on two models,an in vivo open chest rat coronary artery occlusion model and an in vitro model with H9c2 myogenic cells. In both models, 3 groups were constituted and randomly designated as the sham, I/R and IPoC/hypoxia postconditioning (HPoC) groups. In the IPoC group, after 45 min of ischemia, hearts were allowed three cycles of reperfusion/ischemia phases (each of 30 s duration)followed by reperfusion. In the HPoC group, after 6 h of hypoxia, H9c2 cells were subjected to three cycles of 10 minute reoxygenation and 10 minute hypoxia followed by reoxygenation. IPoC significantly reduced the infarct size, plasma level of Lactate dehydrogenase and creatine kinase MB in rats. 12 h after the reperfusion,MIP2 mRNA levels in the IPoC group were 10 folds that of the sham group and 1.4 folds that of the I/R group. Increased expression of MIP2 mRNA and attenuation of apoptosis were similarly observed in the HPoC group in the in vitro model. These effects were blunted by transfection with MIP2 siRNA in the H9c2cells. This study demonstrated that IPoC induced protection was associated with increased expression of MIP2. Both MIP2 overexpression and MIP2 suppression can influence the IPoC induced protection.

Integrated Protection Unit Design for Power Networks

Zhan-feng Fan,Sheng-ming Ge,Z Q Bo,Lin Wang,Feng-quan Zhou,Xing Liu,Guo-bing Song 보안공학연구지원센터 2016 International Journal of Grid and Distributed Comp Vol.9 No.4

This paper presents an hardware design solution for integrated protection of distribution systems (Network Protection Unit) by combining transient polarity comparison technique, which is based on the detection and processing of fault generated transient current signals. The integrated protection relays installed at each substation of a distribution network are communicated with the Network Protection Unit through specially designed Packet Transport Network (PTN) for fast and reliable transmission of transient polarity current signals. The relay detects the faulted generated super-imposed current signals. The transient polarity identification algorithm is then applied to the super-imposed signals to identify the polarity of the signal detected. The Network Protection Unit can collect all the transient polarity current signals under its protection area. Then The direction of a fault is determined by comparison of the polarity of the signals derived from all the line sections connected to the substation. The actual faulted section is identified by the Network Protection Unit through comparing the directional information from various stations. Simulation results presented in the paper demonstrate the feasibility of the scheme.

Electrochemical Cr(VI) reduction using a sacrificial Fe anode: Impacts of solution chemistry and stoichiometry

Chuang, Sheng-Ming,Ya, Vinh,Feng, Chiao-Lin,Lee, Shou-Jen,Choo, Kwang-Ho,Li, Chi-Wang Elsevier 2018 Separation and purification technology Vol.191 No.-

<P><B>Abstract</B></P> <P>A systematic investigation of Cr(VI) reduction using electrochemical reduction revealed that the Cr(VI) reduction was extremely fast with reaction kinetics limited by the anodic generation of Fe(II). The Cr(VI) reduction rate increased with decreasing pH at the initial stage of reaction but the time to reach complete Cr(VI) reduction is pH independent. The amount of Fe(II) generated per mole of Cr(VI) reduced was calculated and compared with the stoichiometric value, i.e., 3mole of Fe(II) needed per mole of Cr(VI) reduced. The values are 11.1% higher than the stoichiometric value for pH 7 and 9, but are 32.0% less for pH 3 and 5. The spontaneous reduction of Cr(VI) by Fe<SUP>0</SUP> and adsorption of Cr(VI) to Fe(OH)<SUB>3</SUB> precipitates might contribute the additional Cr(VI) removal. Effect of DO was investigated under various mixing schemes. Under N<SUB>2</SUB> purging, Fe(II) generated for one mole of Cr(VI) reduced is 3.67% higher than the stoichiometric value, while mechanic mixing and aeration mixing show 15% and 19%, respectively, higher than stoichiometric value, indicating that DO does impact Cr(VI) reduction. The electrochemical Cr(VI) reduction process was also employed to treat electroplating wastewater with and without pH pre-adjustment, achieving 100% total Cr and Ni removal for both cases. ORP can be used as a controlling parameter when electrochemical reduction is implemented for Cr(VI) reduction.</P> <P><B>Highlights</B></P> <P> <UL> <LI> Effect of current on Cr(VI) reduction under same current density was studied. </LI> <LI> Effects of initial and fixed pH on Cr(VI) reduction were investigated. </LI> <LI> Effect of DO on Cr(VI) reduction was explored. </LI> <LI> Electrochemical reduction was applied for treating electroplating wastewater. </LI> <LI> ORP is an ideal parameter for controlling electrochemical Cr(VI) reduction. </LI> </UL> </P>

hARIP2 is a Putative Growth-promoting Factor Involved in Human Colon Tumorigenesis

Gao, Rui-Feng,Li, Zhan-Dong,Jiang, Jing,Yang, Li-Hua,Zhu, Ke-Tong,Lin, Rui-Xin,Li, Hao,Zhao, Quan,Zhang, Nai-Sheng Asian Pacific Journal of Cancer Prevention 2014 Asian Pacific journal of cancer prevention Vol.15 No.20

Activin is a multifunctional growth and differentiation factor of the growth factor-beta (TGF-${\beta}$) superfamily, which inhibits the proliferation of colon cancer cells. It induces phosphorylation of intracellular signaling molecules (Smads) by interacting with its type I and type II receptors. Previous studies showed that human activin receptor-interacting protein 2 (hARIP2) can reduce activin signaling by interacting with activin type II receptors; however, the activity of hARIP2 in colon cancer has yet to be detailed. In vitro, overexpression of hARIP2 reduced activin-induced transcriptional activity and enhanced cell proliferation and colony formation in human colon cancer HCT8 cells and SW620 cells. Also, hARIP2 promoted colon cancer cell apoptosis, suggesting that a vital role in the initial stage of colon carcinogenesis. In vivo, immunohistochemistry revealed that hARIP2 was expressed more frequently and much more intensely in malignant colon tissues than in controls. These results indicate that hARIP2 is involved in human colon tumorigenesis and could be a predictive maker for colon carcinoma aggressiveness.